Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASGR1 | P07306 | 12/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30063180 | 0.79 | ASGR1 (0.52) | ASGR1IRAK4HCRTR1HCRTR2TAS2R14 | |
| SCHEMBL24725263 | 0.79 | ASGR1 (0.52) | ASGR1IRAK4HCRTR1HCRTR2TAS2R14 | |
| SCHEMBL31376879 | 0.76 | ASGR1 (0.46) | ASGR1IRAK4HCRTR1HCRTR2 | |
| SCHEMBL31376918 | 0.74 | ASGR1 (0.42) | ASGR1IRAK4HCRTR1HCRTR2TAS2R14 | |
| SCHEMBL31376887 | 0.74 | ASGR1 (0.42) | ASGR1HCRTR1HCRTR2 | |
| SCHEMBL31376897 | 0.72 | ASGR1 (0.45) | ASGR1HCRTR1HCRTR2 | |
| SCHEMBL31376910 | 0.71 | ASGR1 (0.38) | ASGR1 | |
| SCHEMBL24725115 | 0.70 | ASGR1 (0.35) | ASGR1HCRTR1HCRTR2 | |
| SCHEMBL24725419 | 0.70 | ASGR1 (0.34) | ASGR1HCRTR1HCRTR2 | |
| SCHEMBL31376876 | 0.69 | ASGR1 (0.37) | ASGR1IRAK4HCRTR1HCRTR2TAS2R14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235814-A1 | POTENT ASGPR-BINDING HETEROBIFUCTIONAL COMPOUNDS FOR THE DEGRADATION OF TARGETED EXTRACELLULAR PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| WO-2025235797-A1 | POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS COMPRISING ANTIBODIES FOR THE DEGRADATION OF TARGETED PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2025-11-13 | — | — | WO | disclosed |